Daan Gene Co Ltd banner
D

Daan Gene Co Ltd
SZSE:002030

Watchlist Manager
Daan Gene Co Ltd
SZSE:002030
Watchlist
Price: 6.3 CNY -0.63%
Market Cap: ¥8.8B

Operating Margin

-97.2%
Current
Declining
by 52.9%
vs 3-y average of -44.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-97.2%
=
Operating Income
¥-744m
/
Revenue
¥765.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-97.2%
=
Operating Income
¥-744m
/
Revenue
¥765.5m

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Daan Gene Co Ltd
SZSE:002030
8.8B CNY
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
395.8B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
202.7B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
188B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.5B USD
Loading...
AU
CSL Ltd
ASX:CSL
73.4B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44.2B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 95% of companies in China
Percentile
5th
Based on 8 544 companies
5th percentile
-97.2%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Daan Gene Co Ltd
Glance View

Market Cap
8.8B CNY
Industry
Biotechnology

Daan Gene Co., Ltd., a pioneer in China’s biotechnology scene, originated from the forward-thinking minds at Sun Yat-sen University. With its inception in 1993, the company swiftly positioned itself as a leader in the field of diagnostics, leveraging cutting-edge molecular biology technology. Comprising an initial team of scientific innovators, Daan Gene was poised to address the burgeoning need for rapid and accurate diagnostic solutions within the medical community. Their journey began with an unyielding focus on research and development, concentrating efforts on PCR (polymerase chain reaction) diagnostics. This core technology underpinning the company's offerings allowed Daan Gene to seamlessly transition research breakthroughs into practical, scalable diagnostic tools. Today, Daan Gene thrives by harnessing its advanced molecular diagnostic products, which serve hospitals, research institutions, and enterprises globally. The company's main revenue streams are driven by its expansive range of diagnostic kits and instruments, which address critical needs in infectious diseases, genetic testing, and oncology. With precision and efficiency at the heart of its operations, Daan Gene continually expands its product lineup, marketing its kits to healthcare providers who demand rapid and reliable diagnostic tools. This customer-centric approach enriches Daan Gene's reputation as a trusted partner in healthcare, fortifying its financial growth and staking its claims in the global diagnostics market.

Intrinsic Value
7.05 CNY
Undervaluation 11%
Intrinsic Value
Price
D
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-97.2%
=
Operating Income
¥-744m
/
Revenue
¥765.5m
What is Daan Gene Co Ltd's current Operating Margin?

The current Operating Margin for Daan Gene Co Ltd is -97.2%, which is below its 3-year median of -44.3%.

How has Operating Margin changed over time?

Over the last 3 years, Daan Gene Co Ltd’s Operating Margin has decreased from 58.2% to -97.2%. During this period, it reached a low of -109.7% on Jun 30, 2025 and a high of 58.2% on Aug 30, 2022.

Back to Top